Ensysce Biosciences (ENSC) EBITDA Margin (QoQ) (2020 - 2025)
Ensysce Biosciences (ENSC) EBITDA Margin (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Ensysce Biosciences | 943,416.38 | -3.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -63,104.00 |
| Jun 30, 2025 | 2,144.00 |
| Mar 31, 2025 | 12,526.00 |
| Dec 31, 2024 | -29,320.00 |
| Sep 30, 2024 | 109,448.00 |
| Jun 30, 2024 | -47,279.00 |
| Mar 31, 2024 | 989.00 |
| Dec 31, 2023 | 911.00 |
| Sep 30, 2023 | -15,412.00 |
| Jun 30, 2023 | -14,335.00 |
| Mar 31, 2023 | 10,822.00 |
| Dec 31, 2022 | 177,373.00 |
| Sep 30, 2022 | 119,426.00 |
| Jun 30, 2022 | -260,421.00 |
| Mar 31, 2022 | -67,364.00 |
| Dec 31, 2021 | 128,356.00 |
| Sep 30, 2021 | -131,345.00 |
| Jun 30, 2021 | 11,640.00 |
| Mar 31, 2021 | 5,328.00 |
| Dec 31, 2020 | -21,360.00 |